Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector

Research in Virology

Volumn 149, Issue 6, 1998, Pages 419-431

  Marcello, A ^a,b   Giaretta, I ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

AIDS; Bicistronic vector; Suicide mechanism; Gene therapy; HIV1; Thymidine kinase

Indexed keywords

ACICLOVIR; GANCICLOVIR; PHOSPHOTRANSFERASE; THYMIDINE KINASE; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CISTRON; CONCENTRATION (PARAMETERS); CYTOTOXICITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE THERAPY; HELPER CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE;

ANIMALIA; DNA VIRUSES; ENCEPHALOMYOCARDITIS VIRUS; HERPES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

EID: 0032209155     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(99)80010-7     Document Type: Article

References (59)

1. Abram, C.L., Page, M.J. & Edwards, P.A. (1997), A new retrovirai vector, CA1, to identify and select for cells expressing an inserted gene in vitro and in vivo. Gene, 196, 187-189.
2. Aldovini, A. & Young, R.A. (1990), Mutations and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol., 59, 284-291.
3. Antonelli, G., Turriziani, O., Verri, A., Narciso, P., Ferri, F., D'Offizi, G. & Dianzani, F. (1996), Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. AIDS Res. Hum. Retroviruses, 12, 223-228.
4. Antoni, B.A., Stein, S.B. & Rabson, A.B. (1994), Regulation of human immunodeficiency virus infection: implications for pathogenesis, in "Advances in virus research 43", Vol. 43 (pp. 53-145) Academic Press.
5. Biasolo, M.A., Radaelli, A., Del Pup, L., Franchin, E., De Giuli-Morghen, C. & Palu', G. (1996), A new antisense tRNA construct for the genetic tratment of human immunodeficiency virus type 1 infection. J. Virol., 70, 2154-2161.
6. Brady, H.J.M., Miles, C.G., Pennington, D.J. & Dzierzak, E.A. (1994), Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc. Nat. Acad. Sci., USA, 91, 365-369.
7. Buonocore, L. & Rose, J.K. (1990), Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature, 345, 625-628.
8. + cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc. Nat. Acad. Sci., USA, 89, 182-186.
9. Caruso, M., Salomon, B., Brisson, E., Clavel, F., Lowy, I. & Klatzmann, D. (1995), Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription. Virology, 206, 495-503.
10. Chakrabarti, B.K., Maitra, R.K., Ma, X.-Z. & Kestler, H.W. (1996), A candidate live inactivatable attenuated vaccine for AIDS. Proc. Nat. Acad. Sci., USA, 93, 9810-9815.
11. Chenciner, N., Pedroza Martins, L., Hanania, N., Stratford Perricaudet, L., Perricaudet, M. & Wain-Hobson, S. (1995), Residual expression of reporter genes in constructs mimicking HIV genome organization. Res. Virol., 146, 171-178.
12. Clavel, F. & Orenstein, J.M. (1990), A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol., 64, 5230-5234.
13. Connors, T.A. (1995), The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Therapy, 2, 702-709.
14. Corbeau, P., Kraus, G. & Wong-Staal, F. (1996), Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging line. Proc. Nat. Acad. Sid., USA, 93, 14070-14075.
15. Corbeau, P. & Wong-Staal, F. (1998), Anti-HIV effects of HIV vectors. Virology, 243, 268-274.
16. Di Ianni, M., Casciari, C., Ciurnelli, R., Fulvi, A., Bagnis, C., Sadelain, M., Lucheroni, F., Mannoni, P., Stella C.C., Martelli, M.F. & Tabilio, A. (1997), Retroviral transfer of herpes simplex virus-tymidine kinase and beta-galactosidase genes into U937 cells with a bicistronic vector. Leuk. Res., 21, 951-959.
17. Drake, R.R., McMasters, R., Krisa, S., Hume, S.D., Rechtin, T.M., Saylors, R.L., Chiang, Y., Govindarajan, R. & Munshi, N.C. (1997), Metabolism and activities of 3′-azido-2′, 3′-dideoxythymidine and 2′,3′-didehydro-2′,3′-dideoxythymidine in herpesvirus thymidine kinase transduced T lymphocytes. Antiviral Res., 35, 177-185.
18. Finzi, D., Hermankova, M., Pierson, T., Carruth, L.M., Buck, C., Chaisson, R.E., Quinn, T.C., Chadwick, K., Margolik, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D.D., Richman, D.D. & Siliciano, R.F. (1997), Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science, 278, 1295-1300.
19. Gallardo, H.F., Tan, C. & Sadelain, M. (1997), The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Therapy, 4, 1115-1119.
20. Ghattas, I.R., Sanes, J.R. & Majors, J.E. (1991), The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol., 11, 5848-5859.
21. Guettari, N., Loubiere, L., Brisson, E. & Klatzmann, D. (1997), Use of herpes virus thymidine kinase to improve the antiviral activity of zidovudine. Virology, 235, 398-405.
22. Harrison, G.S., Maxwell, F., Long, C.J., Rosen, C.A., Glode, L.M. & Maxwell, I. (1991), Activation of a diphteria toxin A gene by expression of human immunodeficiency virus-1 tat and rev proteins in transfected cells. Human Gene Therapy, 2, 53-60.
23. Hayashi, T., Shioda, T., Iwakura, Y. & Shibuta, H. (1992), RNA packaging signal of human immunodeficiency virus type 1. Virology, 188, 590-599.
24. Haynes, B.F., Pantaleo, G. & Fauci, A.S. (1996), Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271, 324-328.
25. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. & Markovitz, M. (1995), Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123-129.
26. Jacobsson, B., Britton, S., He, Q., Karlsson, A. & Eriksson, S. (1995), Decreased thymidine kinase levels in periphral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res. Hum., Retroviruses, 11, 805-811.
27. Ishikawa, Y. & Homcy, C. (1992), High efficiency gene transfer into mammalian cells by a double transfection protocol. Nucl. Acid Res., 20, 4367.
28. Jolly, D. (1994), Viral vectors systems for gene therapy. Cancer Gene Therapy, 1, 51-64.
29. Kao, S.Y., Calman, A.F., Luciw, P.A. & Peterlin, B.M. (1987), Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature, 330, 489-483.
30. Leber, S.M., Yamagata, M. & Sanes, J.R. (1996), Gene transfer using replication defective retroviral and adenoviral vectors. Methods Cell. Biol., 51, 161-183.
31. Lever, A., Gottlinger, H., Haseltine, W. & Sodroski, J. (1989), Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol., 63, 4085-4087.
32. Levine, F., Kuan Yee, J. & Friedmann, T. (1991), Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector. Gene, 108, 167-174.
33. Loregian, A., Scremin, C., Schiavon, M., Marcello, A. & Palù, G. (1994), Quantitative analysis of ribonucleotide triphosphates in cell extracts by high-performance liquid chromatography and micellar electrokinetic capillary chromatography: a comparative study. Anal. Chem., 66, 2981-2984.
34. Malirn, M.H., Bohnlein, S., Hauber, J. & Cullen, B.R. (1989), Functional dissection of the HIV-1 rev transactivator, derivation of a transdominant repressor of rev function. Cell, 58, 205-214.
35. Marasco, W.A., Haseltine, W.A. & Chen, S.Y. (1993), Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Nat. Acad. Sci., USA, 90, 7889-7893.
36. Marsden, H.S., Haarr, L. & Preston, C.M. (1983), Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons. J. Virol., 46, 434-445.
37. Morgan, R.A., Couture, L., Elroy-Stein, O., Ragheb, J., Moss, B. & Anderson, F. (1992), Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications in human gene therapy. Nucl. Acid Res., 20, 1293-1299.
38. Mullen, C.A. (1994), Metabolic suicide genes in gene therapy. Pharmac. Therapy, 63, 199-207.
39. Murakami, M., Watanabe, H., Niikura, Y., Kameda, T., Saitoh, K., Yamamoto, M., Yokouchi, Y., Kuroiwa, A., Mizumoto, K. & Iba, H. (1997), High level expression of exogenous genes by replication-competent retrovirus vectors with an internal ribosomal entry site. Gene, 202, 23-29.
40. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. & Trono, D. (1996), In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272, 263-267.
41. Obaru, K., Fujii, S., Matsusbita, S., Shimada, T. & Takatsuki, K. (1996), Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1. Human Gene Therapy, 7, 2203-2208.
42. Parolin, C., Dorfman, T., Palù, G., Gottlinger, H. & Sodroski, J. (1994), Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol., 68, 3888-3895.
43. Parolin, C., Taddeo, B., Palù, G. & Sodroski, J. (1996), Use of cis-and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology, 222, 415-422.
44. Perelson, A.S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. & Ho, D.D. (1997), Decay characteristics of HIV-1-infected compartments during combination therapy. Nature, 387, 188-191.
45. Poznansky, M., Lever, A., Bergeron, L., Haseltine, W. & Sodroski, J. (1991), Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol., 65, 532-536.
46. Ratner, L., Haseltine, W., Patarca, R., Livak, K.J., Starcich, B., Josephs, S.J., Doran, E.R., Rafalski, J.A., Whitehorn, E.A., Baumeister, K., Ivanoff, L., Petteway, S.R., Pearson, M.L., Lautenberger, J.A., Papas, T.S., Ghrayeb, J., Chang, N.T. & Gallo, R.C. (1985), Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, 313, 277-283.
47. Salomon, B., Maury, S., Loubiere, L., Caruso, M., Onclerq, R. & Klatzmann, D. (1995), A truncated herpes simplex virus thymidine kinase phophorylates thymidine and nucleoside analogs and does not cause sterility in mice. Mol. Cell. Biol., 15, 5322-5328.
48. Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A. & Rossi, J.J. (1990), Ribozymes as potential HIV-1 therapeutic agents. Science, 247, 1222-1225.
49. Sczakiel, G. & Pawlita, M. (1991), Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J. Virol., 65, 468-472.
50. Smith, S.M., Markham, R.B. & Jeang, K.-T. (1996), Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function. Proc. Nat. Acad. Sci., USA, 93, 7955-7960.
51. Sokolic, R.A., Sekhsaria, S., Sugimoto, Y., Whiting-Theobald, N., Linton, G.F., Gottesman, M.M. & Malech, H.L. (1996), A bicistronic retrovirus containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood, 87, 42-50.
52. Sugimoto, Y., Aksentijevich, I., Gottesman, M.M. & Pastan, I. (1994), Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site. Bio/technology, 12, 694-698.
53. Sugimoto, Y., Sato, S., Tsukahara, S., Suzuki, M., Okochi, E., Gottesman, M.M., Pastan, I. & Tsuruo, T. (1997), Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice. Cancer Gene Ther., 4, 51-58.
54. Sullenger, B.A., Gallardo, H.F., Ungers, G.E. & Gilboa, E. (1990), Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell, 63, 601-608.
55. Trono, D., Feinberg, M.B. & Baltimore, D. (1989), HIV gag mutants can dominantly interfere with the replication of the wild-type virus. Cell, 59, 113-120.
56. Venkatesh, L.K., Arens, M.Q., Subramanian, T. & Chinnadurai, G. (1990), Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector. Proc. Nat. Acad. Sci., USA, 87, 8746-8750.
57. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S. & Shaw, G.M. (1995), Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 373, 117-122.
58. Wong, J.K., Hezareh, M., Gunthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A. & Richman, D.D. (1997), Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 278, 1291-1295.
59. Zeichner, S.L., Kim, J.Y.H. & Alwine, J.C. (1991), Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J. Virol., 2436-2444.